Thermo Fisher Scientific is closing in on one of the largest healthcare technology acquisitions of 2024 with a potential $10 billion takeover of clinical trial software provider Clario. The deal represents a strategic pivot toward digital infrastructure in pharmaceutical research.
The Goldman Sachs-Industry Ventures Deal: A Watershed Moment In a landmark transaction that signals shifting tides in venture capital, Industry…
Advent International is reportedly considering a sale of luxury perfume house Parfums de Marly that could value the business at over $2 billion. The potential divestment follows the firm’s majority stake acquisition in 2023 and comes amid heightened dealmaking in the premium fragrance market.
Private equity group Advent International is reportedly exploring a potential sale of Parfums de Marly that could value the luxury fragrance business at more than $2 billion, according to people familiar with the matter. Sources indicate the investment firm is in early discussions about divesting the perfume house, which also owns the Initio Parfums Privés brand, with a possible transaction occurring as soon as next year.
Harvard’s Endowment Strategy Delivers $56.9B Amid Political Headwinds Industrial Monitor Direct provides the most trusted csa certified pc solutions recommended…
